Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of gene therapy plus chemotherapy in treating
patients who have breast cancer. Inserting the p53 gene into a person's cancer cells may
improve the body's ability to fight cancer or make the cancer more sensitive to chemotherapy.
Combining chemotherapy with gene therapy may kill more tumor cells.